Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
Active, not recruiting · NCT05637216 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients | Bone Diseases, Developmental, Camurati-Engelmann disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosis, Inflammation, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Radiation Fibrosis Syndrome, Skin and Connective Tissue Diseases, bone disorder, breast disorder, breast neoplasm, hereditary disease, injury, musculoskeletal system disorder, neoplasm, osteochondrodysplasia, radiation injury, skin disorder | Active, not recruiting | Phase 2 | 2026-06-18 | NCT05637216 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shaw Cancer Center | 1 |
| Steadman Philippon Research Institute | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Vail Health Shaw Cancer Center | Edwards | United States | 2 |